17beta-Neriifolin

CAS: 466-07-9

Ref. TR-N390105

Produktinformation

• Name: 17beta-Neriifolin
• Synonyme: 3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one, (3-beta,5-beta)-3-[(6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, (3alpha,5beta,8xi,9xi)-3-[(6-deoxy-3-O-methyl-beta-D-glycero-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, (3beta,5beta)-3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, (3beta,5beta,8xi,9xi)-3-[(6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, (3beta,5beta,8xi,9xi,17xi)-3-[(6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, (3β,5β)-3-[(6-Deoxy-3-O-methyl-α-<span class="text-smallcaps">L</span>-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, 17β-Neriifolin, Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-α-<span class="text-smallcaps">L</span>-glucopyranosyl)oxy]-14-hydroxy-, (3β,5β)-, NSC 123976

Beschreibung

Applications 17β-neriifolin could be considered a candidate for the treatment of hepatocellular carcinoma. It can also work as an inhibitor of hERG channel trafficking.
References Zhao, Q., et al.:Fitoterapia, 82, 735 (2011); Wang, L., et al.: J. Pharmacol. Exper. Ther., 320, 525 (2007)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 534.68
• Formel: C₃₀H₄₆O₈
• Farbe/Form: Neat
• InChl: InChI=1S/C30H46O8/c1-16-24(32)26(35-4)25(33)27(37-16)38-19-7-10-28(2)18(14-19)5-6-22-21(28)8-11-29(3)20(9-12-30(22,29)34)17-13-23(31)36-15-17/h13,16,18-22,24-27,32-34H,5-12,14-15H2,1-4H3/t16-,18+,19-,20+,21-,22+,24-,25-,26+,27-,28-,29+,30-/m0/s1
• InChI Key: InChIKey=VPUNMTHWNSJUOG-OEZZFTQDSA-N
• SMILES: COC1C(O)C(O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@@H]3C2)O[C@@H](C)[C@@H]1O